{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:51:37Z","timestamp":1779893497449,"version":"3.53.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Backgrounds<\/jats:title><jats:p>Diabetic cardiomyopathy has a very high incidence and serious clinical consequences, making it an urgent clinical problem to be solved. Angiogenesis is a significant phenotype in the occurrence and development of diabetic cardiomyopathy, especially the damage to angiogenesis of cardiac microvessels, which is inextricably linked to the cardiac risk of diabetic patients. In the current basic and clinical research, there is still a lack of treatment methods that directly target the angiogenesis of diabetic cardiomyopathy. This study hopes to discover the key molecules related to diabetic cardiomyopathy and angiogenesis damage, to provide ideas for possible interventions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sequencing data of animals and cells were obtained from the GEO database, and differentially expressed genes were analyzed. Subsequently, the angiogenesis-related genes were clustered for functional and pathway analysis. Then, the microangiogenesis of the diabetic mice and the angiogenesis changes of high glucose-stimulated HUVECs were verified, and the top three genes related to diabetic cardiomyopathy and angiogenesis were verified using western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>24 differentially expressed genes associated with angiogenesis were found in GSE241565(human) and GSE215979(mice). Among them, 11 genes showed the same trend in the two databases. Then CD31 staining of diabetic mice hearts showed that microvascular angiogenesis was impaired, high glucose-stimulated HUVECs decreased tube formation, and wound healing migration was weakened. Finally, the top 3 genes most associated with diabetic cardiomyopathy were verified, and there was no significant difference between the changes of Edn1 and Lepr. At the same time, Efnb2 was significantly increased under high glucose stimulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Combined with the sequencing data of animal and cell models of diabetic cardiomyopathy, the differential genes associated with angiogenesis were screened. These findings not only elucidate a novel molecular axis linking angiogenesis damage to diabetic cardiomyopathy but also highlight Efnb2 as a potential therapeutic target.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1561142","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:11:00Z","timestamp":1744863060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Fengli","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2. Diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-024-02239-6","article-title":"Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice","volume":"23","author":"Sun","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00018-024-05257-5","article-title":"Cardiac-specific PFKFB3 overexpression prevents diabetic cardiomyopathy via enhancing OPA1 stabilization mediated by K6-linked ubiquitination","volume":"81","author":"Luo","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1038\/s41598-023-37378-5","article-title":"Identification of hub genes and potential ceRNA networks of diabetic cardiomyopathy","volume":"13","author":"Hou","year":"2023","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5683.20.05454-7","article-title":"Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage","volume":"70","author":"Elia","year":"2022","journal-title":"Minerva Cardiol Angiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1538\/expanim.24-0027","article-title":"Daphnetin ameliorates diabetic cardiomyopathy by regulating inflammation and endoplasmic reticulum stress-induced apoptosis","volume":"74","author":"Zhao","year":"2024","journal-title":"Exp Anim"},{"key":"B7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13098-024-01389-7","article-title":"Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p\/NLRP3 pathway","volume":"16","author":"Yang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155979","article-title":"Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis","volume":"159","author":"Zhao","year":"2024","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12933-024-02469-8","article-title":"Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-024-06771-x","article-title":"Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy","volume":"15","author":"Zhen","year":"2024","journal-title":"Cell Death Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12933-024-02514-6","article-title":"PACS2\/CPT1A\/DHODH signaling promotes cardiomyocyte ferroptosis in diabetic cardiomyopathy","volume":"23","author":"Xiang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S315362","article-title":"Differences of angiogenesis factors in tumor and diabetes mellitus","volume":"14","author":"Tan","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00018-022-04348-5","article-title":"Biological aspects in controlling angiogenesis: current progress","volume":"79","author":"Akbarian","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.17.2239","article-title":"Effect of diabetes mellitus on the formation of coronary collateral vessels","volume":"99","author":"Abaci","year":"1999","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/hc4801.100352","article-title":"Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion","volume":"104","author":"Werner","year":"2001","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14952","article-title":"FGF21\/FGFR1-\u03b2-KL cascade in cardiomyocytes modulates angiogenesis and inflammation under metabolic stress","volume":"9","author":"Kaur","year":"2023","journal-title":"Heliyon"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JOE-20-0398","article-title":"Apelin\/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction","volume":"249","author":"Li","year":"2021","journal-title":"J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012509","article-title":"Endothelial function assessed by digital volume plethysmography predicts the development and progression of type 2 diabetes mellitus","volume":"8","author":"Hahad","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1563","article-title":"Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice","volume":"65","author":"Wang","year":"2016","journal-title":"Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.931066","article-title":"Identification and verification of immune-related biomarkers and immune infiltration in diabetic heart failure","volume":"9","author":"Zhong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1185062","article-title":"Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis","volume":"15","author":"Cui","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i10.2093","article-title":"Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy","volume":"15","author":"Zheng","year":"2024","journal-title":"World J Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1830","article-title":"Proteomic predictors of incident diabetes: results from the atherosclerosis risk in communities (ARIC) study","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae181","article-title":"The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure","volume":"120","author":"Conning-Rowland","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302382","article-title":"Reversal of high-glucose-induced transcriptional and epigenetic memories through NRF2 pathway activation","volume":"7","author":"Wilson-Verdugo","year":"2024","journal-title":"Life Sci Alliance"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.01.018","article-title":"Single-cell analysis reveals lysyl oxidase (Lox)(+) fibroblast subset involved in cardiac fibrosis of diabetic mice","volume":"54","author":"Li","year":"2023","journal-title":"J Adv Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1416403","article-title":"The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094900","article-title":"Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists","volume":"25","author":"Boshchenko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116694","article-title":"Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways","volume":"477","author":"Cai","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02541-3","article-title":"NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K\/Akt\/mTOR pathway in diabetic myocardial infarction","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11918","article-title":"Diagnostic ultrasound-mediated microbubble cavitation dose-dependently improves diabetic cardiomyopathy through angiogenesis","volume":"47","author":"Zhou","year":"2023","journal-title":"Cell Biol Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123443","article-title":"Identification of biomarkers associated with macrophage polarization in diabetic cardiomyopathy based on bioinformatics and machine learning approaches","volume":"364","author":"Liu","year":"2025","journal-title":"Life Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.933635","article-title":"Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021137","article-title":"Molecular and cellular mechanisms underlying the cardiac hypertrophic and pro-remodelling effects of leptin","volume":"25","author":"Karmazyn","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22081274","article-title":"Adiponectin, leptin, and leptin receptor in obese patients with type 2 diabetes treated with insulin detemir","volume":"22","author":"Olczyk","year":"2017","journal-title":"Molecules"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature09002","article-title":"Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis","volume":"465","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature08995","article-title":"Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis","volume":"465","author":"Sawamiphak","year":"2010","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10456-016-9514-9","article-title":"EphrinB2\/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease","volume":"19","author":"Yang","year":"2016","journal-title":"Angiogenesis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311045","article-title":"EphrinB2 regulates cardiac fibrosis through modulating the interaction of stat3 and TGF-\u03b2\/smad3 signaling","volume":"121","author":"Su","year":"2017","journal-title":"Circ Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41392-024-02019-4","article-title":"EphrinB2-mediated CDK5\/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation","volume":"9","author":"Bai","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210523","article-title":"Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats","volume":"14","author":"Coucha","year":"2019","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00821.2013","article-title":"Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3","volume":"306","author":"Zeng","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-023-02887-7","article-title":"Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism","volume":"21","author":"Zhang","year":"2023","journal-title":"BMC Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314839","article-title":"Effects of cilostazol on angiogenesis in diabetes through adiponectin\/adiponectin receptors\/sirtuin1 signaling pathway","volume":"23","author":"Tseng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2020.01.009","article-title":"Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3","volume":"139","author":"Li","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054396","article-title":"Induction of angiogenesis by genetically modified human umbilical cord blood mononuclear cells","volume":"24","author":"Gatina","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13287-022-03099-1","article-title":"Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Stem Cell Res Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1561142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:11:01Z","timestamp":1744863061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1561142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1561142"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1561142","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"article-number":"1561142"}}